PEGBIO CO-B(02565)to raise HK$300M from placing X

15/12/2025 11:34

(Infocast News) PEGBIO CO-B(02565) announced that on December 12, 2025 , the Company has conditionally agreed to place, through the Joint Placing Agents on a best efforts basis, an aggregate of 5,136,000 Placing Shares to not less than six Placees at a price of HK$58.41 per Placing Share to be issued by the Company.

The total number of 5,136,000 Placing Shares represents approximately 1.81% of the H Shares and approximately 1.31% of the total Shares as enlarged by the allotment and issue of the Placing Shares. The Placing Price of HK$58.41 per Placing Share represents a discount of 10% to the closing price of HK$64.90 per H Share as quoted on the Stock Exchange on December 12, 2025.

The estimated gross proceeds and net proceeds from the Placing will amount to approximately HK$299,993,760 and approximately HK$295,699,826, respectively. The net proceeds from the Placing will be primarily utilized for the following purposes:

(I) Construction of a new-generation intelligent R&D and data platform (Approximately 40% of net proceeds)
(II) Repayment of Loans and Strengthening of the Company’s Capital Structure (Approximately 28% of the net proceeds)
(III) Ongoing and planned R&D of PB-2301 and PB-2309 (Approximately 12% of the net proceeds) (IV) Establishment of a HK subsidiary and acceleration of the Groups’ overseas presence (Approximately 10% of the net proceeds)
V) General Corporate Purposes and Working Capital (Approximately 10% of the net proceeds).

(SY)

Infocast Limited and its information providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.